Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma

Haematologica. 2000 Apr;85(4):437-8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage
  • Disease-Free Survival
  • Female
  • Gene Rearrangement, B-Lymphocyte, Heavy Chain / genetics
  • Humans
  • Immunoglobulin Heavy Chains / genetics
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Rituximab
  • Sensitivity and Specificity

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Immunoglobulin Heavy Chains
  • Rituximab